Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AK119 |
Trade Name | |
Synonyms | AK 119|AK-119|Dresbuxelimab |
Drug Descriptions |
AK119 is a monoclonal antibody targeting CD73, which may lead to decreased adenosine via inhibition of the conversion of adenosine monophosphate (AMP) to adenosine, potentially resulting in anti-tumor activity (J Clin Oncol 2021 39:15_suppl, TPS2675). |
DrugClasses | CD73 Antibody 12 |
CAS Registry Number | 2550560-20-6 |
NCIT ID | C179625 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AK119 | AK119 | 0 | 0 |
AK119 + Cadonilimab | AK119 Cadonilimab | 0 | 1 |